196 related articles for article (PubMed ID: 3946419)
1. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
Hirschhorn R; Ellenbogen A
Am J Hum Genet; 1986 Jan; 38(1):13-25. PubMed ID: 3946419
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity in partial adenosine deaminase deficiency.
Hirschhorn R; Martiniuk F; Roegner-Maniscalco V; Ellenbogen A; Perignon JL; Jenkins T
J Clin Invest; 1983 Jun; 71(6):1887-92. PubMed ID: 6863546
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
4. Partial adenosine deaminase deficiency: another family from southern Africa.
Hart SL; Lane AB; Jenkins T
Hum Genet; 1986 Nov; 74(3):307-12. PubMed ID: 3781559
[TBL] [Abstract][Full Text] [Related]
5. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
[TBL] [Abstract][Full Text] [Related]
6. Two newly identified mutations (Thr233Ile and Leu152Met) in partially adenosine deaminase-deficient (ADA-) individuals that result in differing biochemical and metabolic phenotypes.
Hirschhorn R; Borkowsky W; Jiang CK; Yang DR; Jenkins T
Hum Genet; 1997 Jul; 100(1):22-9. PubMed ID: 9225964
[TBL] [Abstract][Full Text] [Related]
7. Hot spot mutations in adenosine deaminase deficiency.
Hirschhorn R; Tzall S; Ellenbogen A
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6171-5. PubMed ID: 2166947
[TBL] [Abstract][Full Text] [Related]
8. Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.
Hirschhorn R; Tzall S; Ellenbogen A; Orkin SH
J Clin Invest; 1989 Feb; 83(2):497-501. PubMed ID: 2783588
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficiency in combined immunologic deficiency disease.
Meuwissen HJ; Pickering RJ; Pollara B
Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
[TBL] [Abstract][Full Text] [Related]
10. Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
Lee CH; Ziegler JB; Rozenberg MC
Aust N Z J Med; 1979 Oct; 9(5):530-3. PubMed ID: 294907
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.
Akeson AL; Wiginton DA; States JC; Perme CM; Dusing MR; Hutton JJ
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5947-51. PubMed ID: 3475710
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
[TBL] [Abstract][Full Text] [Related]
14. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.
Berkvens TM; Gerritsen EJ; Oldenburg M; Breukel C; Wijnen JT; van Ormondt H; Vossen JM; van der Eb AJ; Meera Khan P
Nucleic Acids Res; 1987 Nov; 15(22):9365-78. PubMed ID: 3684597
[TBL] [Abstract][Full Text] [Related]
15. [Adenosine deaminase deficiency in primary immunodeficiencies (author's transl)].
Belohradsky BH; Hennig N; Marget W; Fudenberg HH
Klin Wochenschr; 1976 Dec; 54(23):1109-15. PubMed ID: 1003869
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
17. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
Uberti J; Peterson WD; Lightbody JJ; Johnson RM
J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
[TBL] [Abstract][Full Text] [Related]
18. Hereditary sever combined immunodeficiency and adenosine deaminase deficiency.
Ackeret C; Llüss HJ; Hitzig WH
Pediatr Res; 1976 Jan; 10(1):67-70. PubMed ID: 1246464
[TBL] [Abstract][Full Text] [Related]
19. An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity.
Jiang C; Hong R; Horowitz SD; Kong X; Hirschhorn R
Hum Mol Genet; 1997 Dec; 6(13):2271-8. PubMed ID: 9361033
[TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
Polmar SH
Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
